CAIRIBU
Collaborating for the Advancement of Interdisciplinary Research in Benign Urology

Teleflex Independent Investigator Initiated Studies

Posted on

Teleflex Independent Investigator Initiated Studies

Teleflex Incorporated is accepting applications for their Investigator Initiated Studies (IIS) Research Grants Program. An investigator-initiated study is a Teleflex supported study initiated, developed, designed, and managed by a qualified third-party investigator who assumes sole responsibility for the conduct and management of the research.

Eligibility

An investigator is responsible for conducting the study in accordance with the protocol (developed by the investigator), applicable institution policies, generally accepted standards of GCP/GLP, and all applicable laws and regulations governing the performance of the study.

Investigator must:
  • Be qualified by training and experience (including appropriate licensure as needed) to lead the proposed research from clinics, hospitals, academic centers, universities, community practice or networks, professional associations, and learned societies.
  • Not be excluded, debarred, suspended, or otherwise ineligible to participate in health-care programs
  • Not be an employee of Teleflex
  • Be the originator of the research idea and author the concept/protocol

Areas of Research Interest

Genitourinary

  • UroLift® studies in challenging anatomical presentations (e.g., large prostate volume, elevated bladder neck)
  • UroLift® combined with focal prostate cancer therapies
  • Optimization of implant density and software-guided procedural planning
  • Novel uses of rectal spacers during cancer treatment by ablative technologies
  • Novel applications of injectable bulking agents

General and Urological Surgery

  • Evaluation of Hem-o-Lok™ PurplePlus™ large ligation clip used in minimally invasive surgical procedures, including short-term and long-term outcomes.
  • Novel uses of Hem-o-lok™ medium-large ligation clip delivered by Auto Endo 5™ Automatic Clip Applier or Hem-o-Lok™ PurplePlus™ large ligation clip delivered by manual appliers.
  • Evaluations of the immediate and 1 year plus outcomes of Weck™ EFX Shield™ fascial closure device for minimally invasive surgical port closures of 10mm to 19mm.

Application Timeline

Submissions must be submitted by: March 28, June 27, September 26, December 19. Applications are reviewed quarterly by the Teleflex Grant Panel in January, April, July and October.